Search Results

BMS-536924 100mg 100mg  | Purity Not Available

Adooq Bioscience

BMS-536924 is an effective inhibitor of IGF-IR, causing a reversion of an IGF-IR – mediated transformed phenotype.

More Information Supplier Page

BMS-536924 10mg 10mg  | Purity Not Available

Adooq Bioscience

BMS-536924 is an effective inhibitor of IGF-IR, causing a reversion of an IGF-IR – mediated transformed phenotype.

More Information Supplier Page

OSI-906 50mg 50mg  | Purity Not Available

Adooq Bioscience

OSI-906 is a potential first-in-class selective small molecule, dual kinase inhibitor of both insulin-like growth factor-1 receptor (IGF-1R) and insulin receptor (IR).

More Information Supplier Page

OSI-906 5mg 5mg  | Purity Not Available

Adooq Bioscience

OSI-906 is a potential first-in-class selective small molecule, dual kinase inhibitor of both insulin-like growth factor-1 receptor (IGF-1R) and insulin receptor (IR).

More Information Supplier Page

OSI-906 10mM * 1mL in DMSO 10mM * 1mL in DMSO  | Purity Not Available

Adooq Bioscience

OSI-906 is a potential first-in-class selective small molecule, dual kinase inhibitor of both insulin-like growth factor-1 receptor (IGF-1R) and insulin receptor (IR).

More Information Supplier Page

OSI-906 100mg 100mg  | Purity Not Available

Adooq Bioscience

OSI-906 is a potential first-in-class selective small molecule, dual kinase inhibitor of both insulin-like growth factor-1 receptor (IGF-1R) and insulin receptor (IR).

More Information Supplier Page

AMG-458 10mg 10mg  | Purity Not Available

Adooq Bioscience

AMG-458 is a potent inhibitor of c-Met with an IC50 value of 60nM and displays selectivity against VEGFR2.

More Information Supplier Page

AMG-458 100mg 100mg  | Purity Not Available

Adooq Bioscience

AMG-458 is a potent inhibitor of c-Met with an IC50 value of 60nM and displays selectivity against VEGFR2.

More Information Supplier Page

XL647 10mg 10mg  | Purity Not Available

Adooq Bioscience

XL647 is an orally bioavailable small-molecule RTK inhibitor that binds to and inhibits several tyrosine receptor kinases that play major roles in tumor cell proliferation and tumor vascularization, including EGFR, HER2, ERBB2, VEGFR and EphB4.

More Information Supplier Page

OSI-027 50mg 50mg  | Purity Not Available

Adooq Bioscience

OSI-027 is a potent, selective and orally bioavailable mTOR kinase inhibitor that inhibits the kinase activity associated with both the TORC1 and TORC2 complexes of mTOR.

More Information Supplier Page